Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Choose a second ETF to run a side-by-side ETF comparison with IQSM, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IQSM ETF 2 | -4.41%– | +0.05%– | +1.90%– | +17.13%– | +39.89%– | n/a– |
| Flows | IQSM ETF 2 | +$45M– | +$60M– | +$61M– | +$44M– | +$219M– | -– |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IQSM ETF 2 | +14.56%– | +20.37%– | +17.45%– | n/a– |
| Max drawdown | IQSM ETF 2 | -5.34%– | -15.27%– | -23.67%– | n/a– |
| Max drawdown duration | IQSM ETF 2 | 13d– | 46d– | 379d– | n/a– |
IQSM | ETF 2 | |
Last sale 3/12/2026 at 1:30 PM | $34.57 | – |
| Previous close 03/12/2026 | $35.30 | – |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IQSM | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IQSM | ETF 2 | |
|---|---|---|
| Last price | $34.57 | – |
| 1D performance | -2.05% | – |
| AuM | $270.02 M | – |
| E/R | 0.16% | – |
IQSM | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | New York Life Investments | – |
| Benchmark | NYLI Candriam U.S. Mid Cap Equity Index | – |
| N° of holdings | 219 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | October 25, 2022 | – |
| ESG | Yes | – |
Total weight of top 15 holdings out of 15
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
